About VYRSA Technologies
VYRSA Technologies is a Healthcare company based in King Of Prussia (United States) founded in 2021, and was acquired by Nevro in November 2023. Sacroiliac joint fusion technologies are specialized in by VYRSA Technologies. Its chief executive, as recorded, is Kevin Thornal. Its focus areas include Traditional Medical Devices. Its legal entity is Vyrsa Technologies, Inc.
Company details
VYRSA Technologies was founded in 2021 and is based in King Of Prussia, United States. Operations are centered in the spine and medical technology sector, with a focus on sacroiliac joint fusion. A comprehensive toolset for minimally invasive surgery approaches, including posterior, lateral, and hybrid methods, is provided. The VYRSApro allograft implant is used in posterior SI joint fusion procedures by physicians.
- Headquarters King Of Prussia, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website vyrsatech.com
- Social LinkedIn Instagram
- Acquired by Nevro (Nov 2023)
- Legal Name Vyrsa Technologies, Inc
Investors in VYRSA Technologies
VYRSA Technologies has secured backing from 1 investor. Prominent investors backing the company include Nevro.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of high-frequency spinal cord stimulation implants | 2006 | nevro.com | Menlo Park, United States |
Investor details for VYRSA Technologies
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of VYRSA Technologies
1 people are tracked at VYRSA Technologies (1 in leadership).
| Name | Role | Group |
|---|---|---|
Kevin Thornal | CEO | Leadership |
Complete people profiles for VYRSA Technologies
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of VYRSA Technologies
2 dated milestones of VYRSA Technologies across 2 years, from founding to its latest funding, stage changes and deals.
- Founded VYRSA Technologies is founded.
- Exit Acquired by Nevro.
Top companies in Traditional Diagnostics & Medical Devices
3 companies that operate in the same segment as VYRSA Technologies (Traditional Diagnostics & Medical Devices) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Materials management solutions are provided for healthcare organizations. | 1892 | Chicago, Illinois, United States | USD 29.13 M | USD 20.63 B | 53,000 | |
3D-printed orthopedic products are manufactured for medical applications. | 1941 | Kalamazoo, Michigan, United States | ||||
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | USD 5.1 B | 13,500 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about VYRSA Technologies
VYRSA Technologies was founded in 2021.
VYRSA Technologies is headquartered in King Of Prussia, United States. It is registered at King Of Prussia, Pennsylvania, United States.
Kevin Thornal is the CEO of VYRSA Technologies, as recorded in our data.
VYRSA Technologies was founded in 2021 and is based in King Of Prussia, United States. Operations are centered in the spine and medical technology sector, with a focus on sacroiliac joint fusion. A comprehensive toolset for minimally invasive surgery approaches, including posterior, lateral, and hybrid methods, is provided. The VYRSApro allograft implant is used in posterior SI joint fusion procedures by physicians.
VYRSA Technologies has 1 investor. Key investors include Nevro.
VYRSA Technologies operates through Vyrsa Technologies, Inc.
Yes. VYRSA Technologies was acquired by Nevro in November 2023.